Jeffery Kutok Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jeffery Kutok.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jeffery Kutok. Jeffery Kutok is Chief Scientific Officer in INFINITY PHARMACEUTICALS, INC. ($INFI) and Chief Scientific Officer in Epizyme, Inc. ($EPZM).
Latest Insider Trading Transactions of Jeffery Kutok
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 07 2021 | EPZM | Epizyme, Inc. | Kutok Jeffery | Chief Scientific Of ... | Sell | S | 8.80 | 2,029 | 17,855 | 54,028 | 56.1 K to 54 K (-3.62 %) |
| Feb 02 2021 | EPZM | Epizyme, Inc. | Kutok Jeffery | Chief Scientific Of ... | Option Exercise | A | 11.02 | 136,663 | 1,506,026 | 136,663 | |
| Feb 02 2021 | EPZM | Epizyme, Inc. | Kutok Jeffery | Chief Scientific Of ... | Grant | A | 0.00 | 28,645 | 0 | 56,057 | 27.4 K to 56.1 K (+104.50 %) |
| Apr 03 2020 | EPZM | Epizyme, Inc. | Kutok Jeffery | Chief Scientific Of ... | Option Exercise | A | 13.68 | 131,580 | 1,800,014 | 131,580 | |
| Apr 03 2020 | EPZM | Epizyme, Inc. | Kutok Jeffery | Chief Scientific Of ... | Grant | A | 0.00 | 27,412 | 0 | 27,412 | 0 to 27.4 K |
| Jan 13 2020 | INFI | INFINITY PHARMACEU ... | Kutok Jeffery | Chief Scientific Of ... | Option Exercise | A | 1.25 | 450,000 | 562,500 | 450,000 | |
| Jan 13 2020 | INFI | INFINITY PHARMACEU ... | Kutok Jeffery | Chief Scientific Of ... | Grant | A | 0.00 | 64,219 | 0 | 77,376 | 13.2 K to 77.4 K (+488.10 %) |
| Jan 07 2019 | INFI | INFINITY PHARMACEU ... | Kutok Jeffery | Chief Scientific Of ... | Option Exercise | A | 1.24 | 155,000 | 192,200 | 155,000 | |
| Aug 17 2018 | INFI | INFINITY PHARMACEU ... | Kutok Jeffery | Chief Scientific Of ... | Sell | S | 2.00 | 6,133 | 12,266 | 0 | 6.1 K to 0 (-100.00 %) |
| Aug 17 2018 | INFI | INFINITY PHARMACEU ... | Kutok Jeffery | Chief Scientific Of ... | Sell | S | 2.01 | 8,180 | 16,421 | 6,133 | 14.3 K to 6.1 K (-57.15 %) |
| Jun 25 2018 | INFI | INFINITY PHARMACEU ... | Kutok Jeffery | Chief Scientific Of ... | Sell | S | 2.00 | 14,313 | 28,695 | 14,313 | 28.6 K to 14.3 K (-50.00 %) |
| Jan 04 2018 | INFI | INFINITY PHARMACEU ... | Kutok Jeffery | Chief Scientific Of ... | Option Exercise | A | 2.23 | 70,000 | 156,100 | 70,000 | |
| Jan 04 2018 | INFI | INFINITY PHARMACEU ... | Kutok Jeffery | Chief Scientific Of ... | Grant | A | 0.00 | 28,626 | 0 | 28,626 | 0 to 28.6 K |
| May 26 2017 | INFI | INFINITY PHARMACEU ... | Kutok Jeffery | Chief Scientific Of ... | Option Exercise | A | 1.74 | 125,000 | 217,500 | 125,000 |
Page: 1